- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
World Am, Inc. (OTCBB:WDAM) today reported that its wholly owned Senz-It subsidiary has appointed Dr. Sudhi Sant as its Director of Engineering. Dr. Sant brings to the assignment more than 17 years of industrial research and development experience in Canada and the U.S.
During that time, Dr. Sant worked in a variety of industries, including electronic materials, biopharmaceuticals, ceramic coatings, capital equipment, data storage, semiconductors, and wafer processing, developing and transferring new processes to manufacturing. For his work, he was awarded three U.S. and worldwide patents for creating an antimicrobial nanocrystalline coating that applied antimicrobial therapeutic agents in a solid form on burn dressings that was among the first commercial nanomaterial in the biomedical field.
Dr. Sant obtained his B. S. in Metallurgical Engineering from the National Institute of Technology in Rourkela, India. He received his M.S. in Metallurgical Engineering and his Ph.D. in Metallurgical and Materials Engineering from Queen's University at Kingston, Canada.
Prior to his new position, Dr. Sant held the following senior level management positions: Director of Technology for PowerMetal Technologies, Carlsbad, Calif; President, Twin Technologies, Garden Grove, Calif.; Technical Manager, OpticNet Inc., Hayward, Calif.; and Manager, West Coast Applications Lab, Veeco Inc., San Jose, Calif.
Dr. Sant has delivered numerous conference presentations, and also has collaborated on scholarly articles that have appeared in prestigious peer reviewed publications such as the Journal of Applied Physics, Philosophical Magazine and Acta BioMaterialia.
"We are extremely fortunate to have recruited such a well rounded and well known person in the scientific community to help guide the potential future of Senz-It," said World Am Chairman & CEO Robert A Hovee. "Sudhi Sant brings a level of accomplishment that hopefully will be enhanced in his years with us as a key member of the Senz-It team."
Said Dr. Sant: "Opportunities like this sometimes only happen once in a person's life. I enjoy the challenges of commercialising technology, and the products that Senz-It is developing are at the cutting edge of nanotechnology. Senz-It is intent on building a world class organization, and I am honored to have been asked to be part of what appears to be a company on its way to greatness."
About World Am, Inc.
World Am has two operating subsidiaries, Senz-It and Isotec. Senz-It represents an innovative advancement in the field of micro-sensors that have applications in homeland security, indoor air quality monitoring, food processing and health care. Its potential products are intended to compete in the developing field of real-time detection and notification devices. Senz-It is being designed to identify patterns of molecules present in liquid, blood and air environments for significantly less cost than current approaches.
Senz-It's sister subsidiary is Isotec, which develops, integrates and supplies passage control security products broadly categorized as access control, weapons control, or materials control systems that rigorously control entry or exit of people and materials into and/or out of a facility, while reducing the need for security personnel. Applications of the technology have been delivered to the commercial, retail and government sectors. Isotec's experience in this field allows it to provide high quality, code compliant, application-optimized solutions at the lowest cost in the shortest timeframe.
Additional information on the company is available at http://www.world-am.com/ .
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward looking statements are further qualified by other factors including, but not limited to those, set forth in the World Am, Inc. Form 10-KSB filing and other filings with the United States Securities and Exchange Commission (available at http://www.sec.gov ). The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.
For more information, please click here
World Am, Inc.
Copyright © PrimeNewswireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Nanosheet growth technique could revolutionize nanomaterial production February 1st, 2016
New record in nanoelectronics at ultralow temperatures January 28th, 2016
NBC LEARN DEBUTS SIX-PART VIDEO SERIES, “NANOTECHNOLOGY: SUPER SMALL SCIENCE” Produced by NBC Learn in partnership with the National Science Foundation, and narrated by NBC News/MSNBC’s Kate Snow, series highlights leading research in nanotechnology January 25th, 2016
Graphene leans on glass to advance electronics: Scientists' use of common glass to optimize graphene's electronic properties could improve technologies from flat screens to solar cells February 12th, 2016
Breaking cell barriers with retractable protein nanoneedles: Adapting a bacterial structure, Wyss Institute researchers develop protein actuators that can mechanically puncture cells February 12th, 2016
Properties of Polymeric Nanofibers Optimized to Treat Damaged Body Tissues February 12th, 2016
Semblant Appoints Donald Cunningham as Chief Commercial Officer January 2nd, 2016